A platform-technology company that provides devices, diagnostics, infection control and imaging for specialists treating a wide range of gastrointestinal diseases.
New Study Shows Full Spectrum Endoscopy Procedure Reduces The ‘Miss Rate’ of Adenomas During Colonoscopy
EndoChoice’s Fuse system receives FDA 510(k) Clearance.
Just what does it take to be a CEO of a successful med-tech startup? What does the journey look like for a CEO that has made it through the process of taking an idea and building a product and business around it? Those questions were answered during the CEO Roundtable at the Southeastern Medical Device Conference (SEMDA), which included the CEO of River Cities Capital Funds’ portfolio company EndoChoice.
To expand its line of endoscopy technology, River Cities’ portfolio company EndoChoice will merge with Peer Medical.
SEMDA’s November 29 meeting to feature EndoChoice CEO and founder Mark Gilreath.
EndoChoice ranks #6 in the health segment on the Inc. 500.